Methionine
VARIOUS
Also known as: L-methionine, S-methionine
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Methionine is a drug catalogued in DrugCentral. DrugCentral lists 1 molecular target, including luxS.
- Molecular targets: luxS (1 listed in DrugCentral).
- ATC code: V03AB26 (Antidotes).
- Molecular formula: C5H11NO2S; molecular weight 149.21 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Contraindications (14)
- Classical phenylketonuria
- Diabetes mellitus
- End stage renal disease
- Heart disease
- Humoral hypercalcemia of malignancy
- Hypercalcemia
- Hypercalciuria
- Hyperlipidemia
- Hypertensive disorder
- Kidney disease
- Kidney stone
- Poisoning by digitalis glycoside
- Sarcoidosis
- Ventricular fibrillation
Mechanism & targets
Molecular targets (1)
| Target | Gene | Action | Activity |
|---|---|---|---|
| S-ribosylhomocysteine lyase | luxS | unknown | Ki 4.21 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
V03AB26 | VARIOUS › ALL OTHER THERAPEUTIC PRODUCTS › ALL OTHER THERAPEUTIC PRODUCTS › Antidotes |
V09IX13 | VARIOUS › DIAGNOSTIC RADIOPHARMACEUTICALS › TUMOUR DETECTION › Other diagnostic radiopharmaceuticals for tumour detection |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Foetal growth restriction | 92.0 |
| Ureteric dilatation | 61.0 |
| Device related sepsis | 44.4 |
| Infantile apnoea | 38.8 |
| Electrolyte imbalance | 38.8 |
| Pyelocaliectasis | 38.3 |
| Paraplegia | 36.5 |
| Gaze palsy | 36.4 |
| Selective eating disorder | 35.6 |
| Quadriplegia | 34.9 |
| Paresis | 33.7 |
| Faecaloma | 33.1 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Methionine is on its molecule page.
| Molecular formula | C5H11NO2S |
|---|---|
| Molecular weight | 149.21 g/mol |
| CAS number | 63-68-3 |
| InChIKey | FFEARJCKVFRZRR-BYPYZUCNSA-N |
| PubChem CID | 6137 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
How does Methionine work?
Its molecular targets in DrugCentral include luxS.
What is the chemical formula of Methionine?
Methionine has the molecular formula C5H11NO2S and a molecular weight of 149.21 g/mol.
Browse: all drugs starting with M · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3347 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL274119 — compound record and bioactivity
- PubChem CID 6137 — chemical identifiers
- DrugBank DB00134 — drug record
- FDA UNII AE28F7PNPL — substance identity
- DailyMed: FDA labels for Methionine — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.